Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation?
- PMID: 19631301
- DOI: 10.1016/j.bone.2009.07.011
Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation?
Abstract
Osteonecrosis of the jaw (ONJ) can be associated with nitrogen-containing bisphosphonates (NBPs) therapy. Various mechanisms of NBP-associated ONJ have been proposed and there is currently no consensus of the underlying pathogenesis. The detailed medical and dental histories of 30 ONJ patients treated with NBPs for malignant diseases (24) or osteoporosis (6) were analyzed. The necrotic bone was resected and analyzed histologically after demineralization. In 10 patients the perinecrotic bone was also resected and processed without demineralization. Alveolar bone samples from 5 healthy patients were used as controls. In 14 ONJ patients, serial technetium-99m-methylene diphosphonate scintigraphic scans were also available and confronted to the other data. Strong radionuclide uptake was detected in some patients several months before clinical diagnosis of ONJ. The medullary spaces of the necrotic bone were filled with bacterial aggregates. In the perinecrotic bone, the bacteria-free bone marrow characteristically showed an inflammatory reaction. The number of medullary inflammatory cells taken as an index of inflammation allowed us to discriminate two inflammation grades in the ONJ samples. Low-grade inflammation, characterized by marrow fibrosis and low inflammatory cells infiltration, increased numbers of TRAP(+) mono- and multineacleated cells was seen in patients with bone exposure<2 cm(2). High-grade inflammation, associated with larger lesions, showed amounts of tartrate-resistant acid phosphatase(+)/calcitonin receptor(-) mono- and multinucleated cells, osteocyte apoptosis, hypervascularization and high inflammatory cell infiltration. The clinical extent of ONJ was statistically linked to the numbers of inflammatory cell. Taken together these data suggest that bone necrosis precedes clinical onset and is an inflammation-associated process. We hypothesize that from an initial focus, bone damage spreads centrifugally, both deeper into the jaw and towards the mucosa before the oral bone exposure and the clinical diagnosis of ONJ.
Comment in
-
Fatigue in bone: a novel phenomenon attributable to bisphosphonate use.Bone. 2010 Feb;46(2):556; author reply 557-8. doi: 10.1016/j.bone.2009.09.026. Epub 2009 Sep 29. Bone. 2010. PMID: 19796720 No abstract available.
Similar articles
-
A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.Clin Ther. 2007 Aug;29(8):1548-58. doi: 10.1016/j.clinthera.2007.08.008. Clin Ther. 2007. PMID: 17919538 Review.
-
Histologic and histomorphometric features of bisphosphonate-related osteonecrosis of the jaws: an analysis of 31 cases with confocal laser scanning microscopy.Bone. 2009 Sep;45(3):406-13. doi: 10.1016/j.bone.2009.05.008. Epub 2009 May 18. Bone. 2009. PMID: 19450715
-
Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings.Clin Oral Investig. 2010 Jun;14(3):271-84. doi: 10.1007/s00784-009-0300-6. Epub 2009 Jun 18. Clin Oral Investig. 2010. PMID: 19536569
-
Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.J Oral Maxillofac Surg. 2009 Jul;67(7):1363-72. doi: 10.1016/j.joms.2009.03.005. J Oral Maxillofac Surg. 2009. PMID: 19531404
-
[Osteonecrosis of the jaw and bisphophonates in oncology].Bull Cancer. 2008 Apr;95(4):413-8. doi: 10.1684/bdc.2008.0617. Bull Cancer. 2008. PMID: 18495570 Review. French.
Cited by
-
Relevance of surgical management of patients affected by bisphosphonate-associated osteonecrosis of the jaws. A prospective clinical and radiological study.Clin Oral Investig. 2014;18(2):391-9. doi: 10.1007/s00784-013-0979-2. Epub 2013 Apr 19. Clin Oral Investig. 2014. PMID: 23604698
-
Marginal structural model to evaluate the association between cumulative osteoporosis medication and infection using claims data.Osteoporos Int. 2017 Oct;28(10):2893-2901. doi: 10.1007/s00198-017-4129-6. Epub 2017 Jul 6. Osteoporos Int. 2017. PMID: 28685279 Free PMC article.
-
Effects of pamidronate on human alveolar osteoblasts in vitro.J Oral Maxillofac Surg. 2012 May;70(5):1081-92. doi: 10.1016/j.joms.2011.05.002. J Oral Maxillofac Surg. 2012. PMID: 21856057 Free PMC article.
-
PRGF exerts a cytoprotective role in zoledronic acid-treated oral cells.Clin Oral Investig. 2016 Apr;20(3):513-21. doi: 10.1007/s00784-015-1528-y. Epub 2015 Jul 23. Clin Oral Investig. 2016. PMID: 26201455
-
Lack of correlation between duration of osteonecrosis of the jaw and sequestra tissue morphology: what it tells us about the condition and what it means for future studies.J Oral Maxillofac Surg. 2010 Nov;68(11):2730-4. doi: 10.1016/j.joms.2010.05.090. J Oral Maxillofac Surg. 2010. PMID: 20869151 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical